Fredrik Henell
Director Ejecutivo en Axcentua Pharmaceuticals AB .
Cargos activos de Fredrik Henell
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
Synphora AB
 Synphora AB Pharmaceuticals: MajorHealth Technology The Swedish company was founded in 2004 by Johan Stjernschantz and is currently led by CEO Fredrik Henell. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - |
Historial de carrera de Fredrik Henell
Antiguos cargos conocidos de Fredrik Henell.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Formación de Fredrik Henell.
| University of Stockholm | Masters Business Admin |
| Karolinska Institutet | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 5 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
Synphora AB
Synphora AB Pharmaceuticals: MajorHealth Technology The Swedish company was founded in 2004 by Johan Stjernschantz and is currently led by CEO Fredrik Henell. | Health Technology |
- Bolsa de valores
- Insiders
- Fredrik Henell
- Experiencia
